Q2 results: Zydus Lifesciences net profit rises 14% to ₹911 crore from ₹801 crore
The firm reports double-digit growth in Q2, revenue up 20% Research & Development (R&D) investments for the quarter stands at ...
Tag: Zydus Lifesciences
Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast
Usnoflast, is a “First-in-class” NLRP3 inhibitor to demonstrate proof-of-concept in Phase 2(a) clinical study in ALS patients Usnoflast was well-tolerated ...
Zydus Lifesciences gets USFDA nod for marketing generic Parkinson’s drug
Zydus receives final approval from USFDA for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg Eligible for ...
Q1FY25 results: Zydus Lifesciences net profit rises 31% to Rs 1,420 cr
Company receives USFDA approval for Valbenazine Capsules Revenue from operations at Rs. 62,075 mn, up 21% YoY Research & Development ...
